SGLT2 inhibitors: further evidence for heart failure with preserved ejection fraction as a metabolic disease?

ABSTRACT:

SUBMITTER: Echouffo-Tcheugui JB 

PROVIDER: S-EPMC8631587 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature